We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01139593
First Posted: June 8, 2010
Last Update Posted: December 9, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Fady I. Sharara, M.D, Virginia Center for Reproductive Medicine
June 6, 2010
June 8, 2010
December 9, 2015
June 2010
November 2015   (Final data collection date for primary outcome measure)
Live birth rate [ Time Frame: 4 years ]
Same as current
Complete list of historical versions of study NCT01139593 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)
A Prospective Randomized Trial Comparing Qam With Qpm Daily Dosing in Assisted Reproductive Technologies
This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm).
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Infertile women between 21 and 44 years old
Infertility
Not Provided
  • morning dose
    women undergoing IVF/ICSi taking their gonadotropin dose in the am
  • evening dose
    Women undergoing IVF/ICSI taking their gonadotropin in the evening
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
128
December 2015
November 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • women between 21-42 undergoing IVF

Exclusion Criteria:

  • women > 45,
  • women with one ovary,
  • donor egg,
  • surrogacy,
  • FET cycles,
  • uterine problems,
  • large fibroids
Sexes Eligible for Study: Female
21 Years to 42 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01139593
VCRM 5
Yes
Not Provided
Not Provided
Fady I. Sharara, M.D, Virginia Center for Reproductive Medicine
Virginia Center for Reproductive Medicine
Not Provided
Not Provided
Virginia Center for Reproductive Medicine
December 2015